Neuregenix specializes in preclinical drug screening service that utilises a range of in vivo CNS and PNS injury models and also cultured primary adult neural cells to investigate drug efficacy, mechanism of action and to support lead development based on medium throughput, high content, neuron survival, axon regeneration and neural repair assays.